Physiologically adaptive prodrug liposomal nanoplatform enables programmable biointerface switching to potentiate cold tumor immunotherapy

Yuanyuan Lu, Tong Qu, Chutong Zang, Xintong Cui, Chenyi Su, Xinrong Liu, Yanzhi Song, Yihui Deng

Open source

DOI
10.1016/j.jconrel.2026.115413
Published
2026-09
Container
Journal of Controlled Release
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jconrel.2026.115413,
  title = {Physiologically adaptive prodrug liposomal nanoplatform enables programmable biointerface switching to potentiate cold tumor immunotherapy},
  author = {Yuanyuan Lu and Tong Qu and Chutong Zang and Xintong Cui and Chenyi Su and Xinrong Liu and Yanzhi Song and Yihui Deng},
  year = {2026},
  journal = {Journal of Controlled Release},
  doi = {10.1016/j.jconrel.2026.115413},
  url = {https://doi.org/10.1016/j.jconrel.2026.115413}
}

RIS

TY  - JOUR
TI  - Physiologically adaptive prodrug liposomal nanoplatform enables programmable biointerface switching to potentiate cold tumor immunotherapy
AU  - Yuanyuan Lu
AU  - Tong Qu
AU  - Chutong Zang
AU  - Xintong Cui
AU  - Chenyi Su
AU  - Xinrong Liu
AU  - Yanzhi Song
AU  - Yihui Deng
PY  - 2026
JO  - Journal of Controlled Release
DO  - 10.1016/j.jconrel.2026.115413
UR  - https://doi.org/10.1016/j.jconrel.2026.115413
ER  - 

APA

Lu, Y., Qu, T., Zang, C., Cui, X., Su, C., Liu, X., Song, Y., & Deng, Y. (2026). Physiologically adaptive prodrug liposomal nanoplatform enables programmable biointerface switching to potentiate cold tumor immunotherapy. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2026.115413

Source records